Comparative Pharmacology
Head-to-head clinical analysis: MANNITOL 20 IN PLASTIC CONTAINER versus OSMITROL 5 IN WATER IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MANNITOL 20 IN PLASTIC CONTAINER versus OSMITROL 5 IN WATER IN PLASTIC CONTAINER.
MANNITOL 20% IN PLASTIC CONTAINER vs OSMITROL 5% IN WATER IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Mannitol is an osmotic diuretic that increases plasma osmolality, drawing water from intracellular compartments into extracellular fluid. In the kidneys, it is freely filtered at the glomerulus but minimally reabsorbed, increasing tubular fluid osmolality and reducing water reabsorption, thereby promoting diuresis. It also reduces cerebral edema by creating an osmotic gradient that draws water from brain tissue into plasma.
Osmotic diuretic that increases plasma osmolality, drawing water from intracellular spaces into extracellular fluid and increasing renal blood flow. It is filtered by glomerulus and not reabsorbed, leading to increased urinary output and reduction of intracranial/intraocular pressure.
Intravenous: 50-100 g (250-500 mL of 20% solution) over 30-60 minutes; may repeat every 6-8 hours as needed. For cerebral edema: 1-2 g/kg IV over 30-60 minutes.
Intravenous infusion. Usual adult dose: 50-100 grams (500-1000 mL of 5% solution) administered over 30-60 minutes. Frequency: every 6-12 hours as needed for cerebral edema or reduction of intraocular pressure.
None Documented
None Documented
Terminal elimination half-life: 0.25–1.7 hours in normal renal function; prolonged in renal impairment.
The terminal elimination half-life is approximately 1.5 to 2 hours in adults with normal renal function. This can be prolonged to 6-12 hours in patients with renal impairment, requiring dose adjustment.
Renal: >90% as unchanged drug. Biliary/fecal: negligible.
Mannitol is excreted primarily by the kidneys via glomerular filtration, with approximately 80% of an administered dose appearing unchanged in urine within 3 hours. Less than 10% undergoes tubular reabsorption; negligible biliary or fecal elimination (<1%).
Category A/B
Category C
Osmotic Diuretic
Osmotic Diuretic